What: 2nd Annual PharmaDiscovery Conference
When: May 10-12, 2006
Where: Bethesday North Marriott Hotel & Conference Center, Maryland, USA
This 3-day multi-track program is targeted to maximize networking opportunitites among leaders in the pharmaceutical industry, academia, regulation and technology development. Among the keynote sessions are:
- Is Innovation Positively or Negatively Impacting Discovery and Development? Dr John L. LaMattina, Senior Vice President, Pfizer Inc and President, Pfizer Global Research and Development
- Bridging the Industry and Academia Divide to Drive Innovation Forward Dr Christopher P. Austin, Director, NIH Chemical Genomics Centre, National Institutes of Health
- How is Industry Responding to the FDA's Critical Path White Paper? 2006 Update
- Dr Janet Woodcock, Deputy Commissioner for Operations and Chief Operating Officer, US Food and Drug Administration
- Drug Hunting from a Drug Hunter Dr Roger Newton, Senior Vice President and Director, Esperion Therapeutics, a Division of Pfizer Global R&D
- Sex in an age of mechanical reproduction: Implications for Drug Innovation Professor Carl Djerassi, Playwright and Emeritus Professor of Chemistry, Stanford University
- Maintaining A Culture of Innovation as the Biotech Industry Evolves Dr. Joseph Miletich, Senior Vice President, Research & Pre-clinical Development. Amgen
.jpg)
Comment Preview